MCAM and melanoma: More recently, Reid et al. [50] found that MCAM/MUC18 was significantly more common in non-surgically treated advanced melanoma patients with a negative treatment outcome than in those with a positive outcome (43 vs 9 %), reasonably related to an ineffective eradication of CMCs.